Skip to content

Amelioration of Lipid Profile Through Date Cider-vinegar Along With 5:2 Intermittent Fasting

Amelioration of Lipid Profile Through Date Cider-vinegar Along With 5:2 Intermittent Fasting Among Prediabetic Individuals

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07710898
Enrollment
108
Registered
2026-07-17
Start date
2026-01-12
Completion date
2026-05-12
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabete Mellitus, Hyperlipidemia, Prediabetes

Keywords

Diabete Mellitus, Prediabetes, Hyperlipidemia, lipid profile, date- cider vinegar

Brief summary

A common metabolic abnormality in hyperglycemic individuals, dyslipidemia is strongly linked to an increased risk of cardiovascular illness. This study looked at how date cider vinegar and 5:2 intermittent fasting affected the lipid profile and metabolic indices of hyperglycemic patients

Detailed description

The target population was adults between the ages of 35 and 65 years who are receiving outpatient care at a hospital or clinic with a diagnosis of either mild to moderate hypertension, dyslipidemia or pre-diabetes. Once consent was given, participants were then be randomly assigned to receive the prescribed intervention or act as a control. The intervention period was 12 weeks. Participants in the experimental groups received date cider vinegar supplementation, with one group additionally following the 5:2 intermittent fasting protocol. The control group received standard dietary advice without vinegar supplementation or fasting intervention. Participants were instructed to follow the assigned intervention daily according to the study protocol. Weekly follow-up visits were conducted to monitor dietary compliance, record self-reported adherence, and assess health outcomes including lipid profile, body weight,and blood pressure. Usual dietary intake was also monitored to ensure consistency and adherence to the intervention. At baseline, nutritional assessment based on weight and height, BMI, waist circumference, blood pressure, fasting blood glucose, lipid panels (HDL, LDL, total cholesterol, triglycerides), and dietary intake analysis were done. After 12 weeks of intervention all the measurements that were done again to compare the results pre- and post-intervention.

Interventions

DRUGControl Group (T 0 )

The control group received standard dietary advice without vinegar supplementation or fasting intervention.

DIETARY_SUPPLEMENTExperimental Group (T 1 )

Participants were advised to take 15 ml of Date Cider Vinegar (DCV) diluted in 1 cup (250ml) of water 15 minutes before breakfast and dinner daily for a duration of 3 months.

COMBINATION_PRODUCTExperimental Group (T 2 )

Participants were advised to follow 5:2 Intermittent Fasting (two non-consecutive fasting days per week) along with DCV intervention for a duration of 3 months. 15 ml of DCV was diluted in 1 cup of water and It was taken 15 minutes before breakfast and dinner daily.

Sponsors

University of Lahore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* The inclusion criterion was target adults with both gender aged 35-65 years. * Adults with a diagnosis of mild to moderate hypertension * Mild hypertension (140-159/90-99 mm Hg) * Moderate hypertension (160-179/100-109 mm Hg) * Adults having mild to moderate alterations in lipid profile * Triglycerides: 150 to 499 mg/dL * LDL-C levels: Mild Alteration (130 to 159 mg/dL) and Moderate Alteration (160 to 189 mg/dL) * Adults with pre-diabetes (hbA1c= 5.6-6.4%) were used. * Patients were solicited from hospital.

Exclusion criteria

* Any Lactating and pregnant women were not included. * Any person allergic to citric acid. * Adults suffering from critical health conditions, including cancer.

Design outcomes

Primary

MeasureTime frameDescription
Body Mass Index3 monthsBMI was calculated by dividing weight (in kg) by the square of height (in meters).

Secondary

MeasureTime frameDescription
Blood pressure3 monthsBlood pressure measurements will be taken using an automated sphygmomanometer, with systolic pressure and diastolic pressure being measured while sitting after a 5-minute rest. The average of three readings were used for analysis.
Lipid Profile3 monthsTotal cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides, and high-density lipoprotein cholesterol (HDL-C) levels were measured using enzymatic methods with commercial test kits.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026